# OnCo record pirarubicin (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/pirarubicin/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "pirarubicin" ;
  schema:name "Pirarubicin"@en ;
  schema:alternateName "Pinorubin"@en, "THP-adriamycin"@en ;
  schema:description "Pirarubicin is a doxorubicin relative developed in Japan and used there and in China for breast cancer, lymphoma, bladder cancer and other tumours, including instillation into the bladder after tumour resection."@en ;
  schema:url <https://onco.cc/drugs/pirarubicin/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Pirarubicin> ;
  schema:citation <https://clinicaltrials.gov/search?intr=Pirarubicin> ;
  onco:status "established" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:modality "Anthracycline (topoisomerase II inhibitor), intravenous or intravesical" ;
  onco:cancers <https://onco.cc/cancers/urothelial/>, <https://onco.cc/cancers/breast-hr-positive/> ;
  onco:technologies <https://onco.cc/technologies/cytotoxic-chemotherapy/> ;
  onco:targets <https://onco.cc/targets/top2a/> ;
  onco:companies <https://onco.cc/companies/nippon-kayaku/> ;
  onco:trials <https://onco.cc/trials/nct07424287/> .